Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Acuren Corporation (TIC : NYSE)

• Company Description    Acuren Corp. is engaged in providing nondestructive testing, inspection, engineering and lab testing services. It operates through following services: Nondestructive Testing, Rope Access Technician Solutions and Engineering and Lab Testing. Nondestructive Testing offerings include breadth of nondestructive testing services including conventional, advanced and tech-enabled NDT. Rope Access Technician Solutions offerings include a full suite of rope access technician offerings including inspection, repair and specialty craft service. Engineering and Lab Testing offerings include materials engineering and lab testing services. Acuren Corp. is based in Road Town, British Virgin Islands. Number of Employees: 6,060

• Price / Volume Information    Yesterday's Closing Price: $11.75 Daily Weekly Monthly 20 Day Moving Average: 2,238,718 shares Shares Outstanding: 121.48 (millions) Market Capitalization: $1,427.35 (millions) Beta: 52 Week High: $14.28 52 Week Low: $8.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.10% 5.01% 12 Week 21.13% 1.89% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 14434 MEDICAL COMPLEX DRIVE SUITE 100 - TOMBALL,TX 77377 USA ph: 800-218-7450 fax: - ir@acuren.com http://www.acuren.com

• General Corporate Information    Officers Talman B. Pizzey - President and Chief Executive Officer Martin E. Franklin - Chairman Kristin B. Schultes - Chief Financial Officer Gregory F. Conaway - Chief Accounting Officer Rory Cullinan - Director Peer Information Acuren Corporation (BJCT) Acuren Corporation (CADMQ) Acuren Corporation (APNO) Acuren Corporation (UPDC) Acuren Corporation (IMTIQ) Acuren Corporation (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 00510N102 SIC: 7389 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/21/25 Share - Related Items Shares Outstanding: 121.48 Most Recent Split Date: (:1) Beta: Market Capitalization: $1,427.35 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/21/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.26 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -61.54% Sales Growth vs. Year Ago Period: 5.00% vs. Previous Quarter: -10.62% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - 3.49 12/31/24 - 3.71 Quick Ratio 06/30/25 - - 03/31/25 - 3.49 12/31/24 - 3.71 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -11.22 Book Value 06/30/25 - - 03/31/25 - 9.29 12/31/24 - 9.48 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.66 12/31/24 - 0.65 Debt-to-Capital 06/30/25 - - 03/31/25 - 39.74 12/31/24 - 39.35

Powered by Zacks Investment Research ©